Skip to main content
Fig. 4 | BMC Musculoskeletal Disorders

Fig. 4

From: Quality of life and cost-effectiveness analysis of topical tranexamic acid and fibrin glue in femur fracture surgery

Fig. 4

Sensitivity analysis of the incremental cost-utility ratio (ICUR). Notes: QALYs: Quality adjusted life years. The variation in QALYs was the 95% Confidence Interval upper (0.106704) and lower (0.040027) value of the mean utility (0.073366) in the topical TXA group. USPPP: $US Purchasing Power Parities are the rates of currency conversion that equalise the purchasing power of different currencies by eliminating the differences in price levels between countries. The variation in topical Tranexamic Acid (TXA) cost ranged from zero (control cost) and 25.8 USPPP, which is 100% higher than the unit cost of TXA

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us